 | |
| Clinical data | |
|---|---|
| Trade names | Dricol, Fentrinol, Nalde |
| Other names | Amidefrine; MJ-1996; MJ-5190; 3-Methylsulfonamidyl-β-hydroxy-N-methylphenethylamine; 3-Methylsulfonamidyl-β-hydroxy-N-methyl-β-phenylethylamine |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H16N2O3S |
| Molar mass | 244.31 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Amidephrine (BANTooltip British Approved Name), oramidefrine, sold under the brand nameFentrinol among others, is aselectiveα1-adrenergic receptoragonist which is described as anadrenergic orsympathomimetic,vasoconstrictor, andtopicalnasal decongestant used to treatallergic rhinitis.[1][2][3][4][5] It is used as themesylatesalt, which has thegeneric namesamidefrine mesilate (INNTooltip International Nonproprietary Name) andamidephrine mesylate (USANTooltip United States Adopted Name).[2] The drug is asubstituted phenethylaminederivative and is also known as 3-methylsulfonamidyl-β-hydroxy-N-methylphenethylamine.[2][1][6] As of 2000, it remained marketed only inAustria.[3]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |
